Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Exchange Rate Effect (2020 - 2025)

Apellis Pharmaceuticals (APLS) has 6 years of Exchange Rate Effect data on record, last reported at $184000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 119.07% year-over-year to $184000.0; the TTM value through Dec 2025 reached $1.2 million, up 289.68%, while the annual FY2025 figure was $1.2 million, 289.68% up from the prior year.
  • Exchange Rate Effect reached $184000.0 in Q4 2025 per APLS's latest filing, up from $22000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $685000.0 in Q2 2025 and bottomed at -$1.6 million in Q1 2021.
  • Average Exchange Rate Effect over 5 years is -$88900.0, with a median of $15000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 959.87% in 2021, then skyrocketed 2237.5% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $8000.0 in 2021, then surged by 2237.5% to $187000.0 in 2022, then surged by 212.3% to $584000.0 in 2023, then tumbled by 265.24% to -$965000.0 in 2024, then soared by 119.07% to $184000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $184000.0 in Q4 2025, $22000.0 in Q3 2025, and $685000.0 in Q2 2025.